The NIDA-funded NDEWS Coordinating Center at UF
The National Drug Early Warning System (NDEWS), funded to the University of Florida by the National Institute on Drug Abuse (NIDA), provides the field with timely, salient, and valuable information on emerging substance use trends.
NDEWS is led by scientists from the University of Florida, New York University, and Florida Atlantic University. Our Coordinating Center (CC) draws heavily on established and emerging public health surveillance methods and integrates expertise from multiple disciplines.
Our Early Warning Network is comprised of scientists from 17 urban, suburban, and rural areas in the US. They regularly collect community-level indicators of drug use, morbidity, and mortality.
Our Scientific Advisory Group is composed of 12 scientists from across the US and 5 experts from relevant government agencies to advise NDEWS leadership on relevant indicators, data harmonization, and interpretation.
One aim of the new NDEWS is to incorporate and leverage novel surveillance methods to ensure early detection of signals of new and emerging drug trends, including data from "drug checking," an ongoing national venue-intercept study, our new Virtual HealthStreet, and the development of an innovative machine learning approach to detect emergence of new psychoactive substances in real-time through algorithms deployed to darknet drug markets and forums.
NDEWS SNOW Dashboard
The State and National Overdose Web (SNOW) is an interactive dashboard directed by NDEWS Co-Investigator Dr. Bruce Goldberger. SNOW contains information regarding drug-related outcomes in participating NDEWS sentinel sites across the United States. SNOW is publicly available and is to be used solely for informational purposes.
NDEWS is excited to announce a new collaboration with the Center for Forensic Science Research & Education (CFSRE)’s NPS Discovery to assist in…
A recently published study by NDEWS Deputy Director Dr. Joseph Palamar examined trends in awareness that cocaine can be adulterated with fentanyl…
Joseph Palamar, PhD, MPH, Associate Professor, Department of Population Health at NYU Langone Medical Center, has been named Deputy Director of…